HOUSTON, TX / ACCESS Newswire / July 9, 2025 / Mann Eye Institute, a leader in innovative eye care since the 1970s, is proud ...

Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...

BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the ...

In patients with neovascular age-related macular degeneration (AMD), one of the most vision-threatening complications is submacular hemorrhage (SMH), a condition that can rapidly destroy central ...

News-Medical is your trusted source of Macular Degeneration news, articles and research for doctors, patients, and families.

The treatment of diabetic macular oedema (DMO) likely involves a series of treatment episodes separated by gaps during which ...

The result was a notable drop in inflammation, with promising results in early models of sepsis and age-related macular degeneration. Related Stories ・Say goodbye to reading glasses: New eye drops are ...

Patients with only dry eye had less severe lid margin abnormalities and orifice plugging along with tear film instability ...

In macular edema, leaky blood vessels make the macula swell, initially causing blurry or wavy vision, according to the National Eye Institute. If left untreated, it can eventually cause blindness.